Related references
Note: Only part of the references are listed.Structure and function of serotonin G protein-coupled receptors
John D. McCorvy et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Connie Sanchez et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Positron Emission Tomography Quantification of Serotonin1A Receptor Binding in Suicide Attempters With Major Depressive Disorder
Gregory M. Sullivan et al.
JAMA PSYCHIATRY (2015)
Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation
A. Shin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Of mice and men: modelling post-stroke depression experimentally
G. Kronenberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Levomilnacipran Extended-Release: A Review of Its Use in Adult Patients with Major Depressive Disorder
Lesley J. Scott
CNS DRUGS (2014)
Modulating the serotonin system in the treatment of major depressive disorder
Debbi Ann Morrissette et al.
CNS SPECTRUMS (2014)
A proposal for an updated neuropsychopharmacological nomenclature
Joseph Zohar et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine
William James Deardorff et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression
Arif Khan et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
Roger S. McIntyre et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus
Elena Dale et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Serotonin 1A receptors and sexual behavior in male rats: A review
Eelke M. S. Snoeren et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Levomilnacipran: a newly approved drug for treatment of major depressive disorder
Rajnish Mago et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
Improving the Treatment of Schizophrenia: Role of 5-HT Receptors in Modulating Cognitive and Extrapyramidal Motor Functions
Saki Shimizu et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2013)
Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
Pau Celada et al.
CNS DRUGS (2013)
Serotonergic Drugs for Depression and Beyond
Stephen M. Stahl et al.
CURRENT DRUG TARGETS (2013)
Individualized Treatment with Antidepressants
S. Koehler et al.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE (2013)
Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
L. Citrome
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2013)
A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder
Rakesh Jain et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
The Effect of Vilazodone on Sexual Function During the Treatment of Major Depressive Disorder
Anita H. Clayton et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets
Gary M. Mawe et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Neuroreceptor imaging in depression
Jonathan B. Savitz et al.
NEUROBIOLOGY OF DISEASE (2013)
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety
A. L. Auclair et al.
NEUROPHARMACOLOGY (2013)
Preclinical and clinical characterization of the selective 5-HT1A receptor antagonist DU-125530 for antidepressant treatment
M. C. Scorza et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The Roles of Neurotrophic Factor and Wnt Signaling in Depression
B. Voleti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Rediscovering Trazodone for the Treatment of Major Depressive Disorder
Andrea Fagiolini et al.
CNS DRUGS (2012)
Vortioxetine (Lu AA21004) in the long-term open-label treatment of major depressive disorder
David S. Baldwin et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review
Merce Masana et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD)
David S. Baldwin et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
The 5-HT7 receptor in learning and memory
Amanda J. Roberts et al.
HIPPOCAMPUS (2012)
A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
Cornelius Katona et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
L. Citrome
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
Enric Alvarez et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Prevalence and correlates of the proposed DSM-5 diagnosis of Chronic Depressive Disorder
Jenifer A. Murphy et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder
Jean-Philippe Boulenger et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Vilazodone for the Treatment of Major Depressive Disorder
Maryam Iranikhah et al.
PHARMACOTHERAPY (2012)
Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
A. Mork et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
New Strategies in the Development of Antidepressants: Towards the Modulation of Neuroplasticity Pathways
Rebeca Vidal et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited
Jolanda Prins et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Triptans for the Management of Migraine
Mollie M. Johnston et al.
DRUGS (2010)
The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?
Ramamoorthy Rajkumar et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
The CRF system, stress, depression and anxiety-insights from human genetic studies
E. B. Binder et al.
MOLECULAR PSYCHIATRY (2010)
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
Mike Briley et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2010)
Serotonin receptor antagonists for highly emetogenic chemotherapy in adults
A. Billio et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression
B. M. Ruf et al.
CURRENT DRUG TARGETS (2009)
Antagonism of serotonergic 5-HT2A/2C receptors: mutual improvement of sleep, cognition and mood?
H. -P. Landolt et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Elevated Serotonin 1A Binding in Remitted Major Depressive Disorder: Evidence for a Trait Biological Abnormality
Jeffrey M. Miller et al.
NEUROPSYCHOPHARMACOLOGY (2009)
The 5-HT7 receptor and disorders of the nervous system: an overview
Peter B. Hedlund
PSYCHOPHARMACOLOGY (2009)
Resolution of sexual dysfunction during acute treatment of major depression with milnacipran
David Baldwin et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Comment on: 'Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence'
Thomas A. Ban
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Prolactin-related and metabolic adverse effects of atypical antipsychotic agents
David C. Henderson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons
Gary A. Gudelsky et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists:: [11C] raclopride PET studies in the rat
Alice Egerton et al.
PSYCHOPHARMACOLOGY (2008)
Selective serotonin reuptake inhibitor discontinuation - Side effects and other factors that influence medication adherence
John W. Goethe et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
A meta-analysis of clinical trials comparing milnacipran, a serotonin-norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder
George I. Papakostas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies
H. G. Ruhe et al.
MOLECULAR PSYCHIATRY (2007)
Altered serotonin 1A binding in major depression: A [carbonyl-C-11]WAY100635 positron emission tomography study
RV Parsey et al.
BIOLOGICAL PSYCHIATRY (2006)
5-ht(5A) receptors as a therapeutic target
David R. Thomas
PHARMACOLOGY & THERAPEUTICS (2006)
Modulation of dopamine release by striatal 5-HT2C receptors
KD Alex et al.
SYNAPSE (2005)
Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635
Z Bhagwagar et al.
MOLECULAR PSYCHIATRY (2004)
Dopamine and serotonin: influences on male sexual behavior
EM Hull et al.
PHYSIOLOGY & BEHAVIOR (2004)
Serotonin transporter occupancy of five selective serotonin Reuptake inhibitors at different doses:: An [11C]DASB positron emission tomography study
JH Meyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Depressed new neurons - Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression
G Kempermann et al.
BIOLOGICAL PSYCHIATRY (2003)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Prevalence of sexual dysfunction among newer antidepressants
AH Clayton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
The possible role of 5-HT1B/D receptors in psychiatric disorders and their potential as a target for therapy
C Moret et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Mirtazapine substitution in SSRI-induced sexual dysfunction
AJ Gelenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635 -: Effects of depression and antidepressant treatment
PA Sargent et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Share Paper
